A Randomized Controlled Trial of Lung Ultrasound Compared to Chest X-ray for Diagnosing Pneumonia in the Emergency Department



Status:Terminated
Conditions:Pneumonia, Hospital
Therapuetic Areas:Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:Any
Updated:4/21/2016
Start Date:August 2012
End Date:July 2013

Use our guide to learn which trials are right for you!

Comparative Effectiveness of Lung Ultrasound vs. Chest X-ray for the Diagnosis of Pneumonia in the Emergency Department

The primary objective of this study is to determine if lung ultrasound (LUS) can replace
chest x-ray (CXR) when evaluating patients with possible pneumonia. Specifically, we are
looking for an overall reduction of CXR when LUS is used first. Our null hypothesis is that
LUS cannot replace CXR for diagnosing pneumonia. Our alternate hypothesis is that LUS can
replace CXR for diagnosing pneumonia. Our secondary objectives include: (1) a comparison of
unscheduled healthcare visits after the index Emergency Department (ED) visit between those
subjects who undergo CXR first and those who undergo LUS first, (2) an evaluation of the
rate of antibiotic use between the two groups, (3) a comparison of the admission rates, and
(4) a comparison of the length of stay in the Emergency Department between the two groups.

Background - Ultrasound is now widely accepted as a diagnostic tool for use in the emergency
department, as supported by the American College of Emergency Physicians position statement
in 2001 (revised in 2008). Evidence-based guidelines for point-of-care lung ultrasound have
recently been published (Volpicelli et al 2012). Lichtenstein et al (2004) performed bedside
LUS on 117 critically ill patients to evaluate for alveolar consolidation and compared these
findings with CT, the gold standard. Sensitivity of ultrasound was 90% and specificity 98%,
indicating that US is a feasible imaging modality for the lungs. Copetti et al (2008)
compared the diagnostic accuracy of LUS and CXR in children with suspected pneumonia. 79
children underwent LUS and CXR. Lung ultrasound was positive for the diagnosis of pneumonia
in 60 patients, whereas CXR was positive in 53. Copetti concluded that LUS is as reliable as
CXR in diagnosing pneumonia plus it has the added benefit of no radiation exposure for
patients. Shah et al (2009) found LUS to be superior to CXR in detecting pneumonia. 200
patients with suspected pneumonia were enrolled and underwent LUS and CXR. LUS detected 49
pneumonias whereas CXR detected 36. The 13 cases of radiographically occult pneumonia that
were identified by LUS were all less than 1 centimeter in diameter, suggesting that LUS is
superior in identifying early and/or small pulmonary consolidations. This particular study
found that LUS was able to detect pneumonia with a Sensitivity of 86% and a Specificity of
97%. Additionally, Tsung et all (2009) found that it is feasible to use ultrasound to
distinguish viral from bacterial pneumonia, thus indicating another striking advantage to
LUS. From these studies, it is clear that lung ultrasound plays a role in the diagnosis of
pulmonary pathology and moreover it is possible that LUS may replace CXR as the imaging
modality of choice. This study is designed as a comparative effectiveness randomized
controlled trial between ultrasound and chest x-ray for diagnosing pneumonia. The study
cited above performed by Shah et al 2009 forms the basis of our pilot data in planning this
randomized controlled trial. In Dr. Shah's study, there were no missed pneumonias and no
over or under treatment of pneumonia when pneumonia was diagnosed on lung ultrasound.

Study Design - Currently CXR is the standard of care for the detection of pneumonia,
however, there is published evidence that demonstrates LUS is as reliable as CXR and even
surpasses CXR in detecting small and/or early pneumonias as well differentiating viral from
bacterial processes as cited above (Lichtenstein et al 2004; Copetti et al 2008; Shah et al
2009; Tsung et al 2012).

The motivation for conducting this study is that we have possibly identified an imaging
modality that is better than our current standard of care. It is our primary aim to compare
the two imaging modalities to clinical outcomes to see if subjects in the investigational
arm have better outcomes than those in the control arm who receive the standard of care.

The attending physician or fellow caring for the patient will determine if the patient is
eligible. If the ED provider clearly identifies a pneumonia on the ultrasound then the
patient will be diagnosed and treated for pneumonia without being subjected to the
unnecessary radiation of a CXR. However, if the provider does not clearly identify a
pneumonia on ultrasound or if the LUS fails to detect a pneumonia and the clinical suspicion
remains high, then the provider has the option to proceed to the CXR to assist in the
diagnosis of pneumonia. Alternatively, all subjects randomized to the control arm will under
a CXR first followed by a LUS, because LUS can often provide additional information that CXR
does not as noted above (e.g. the ability to differentiate between viral and pneumonia
infections).

Inclusion Criteria:

- All patients who present to the ED with respiratory symptoms suspicious for pneumonia

- In whom the treating physician believes would benefit from diagnostic imaging

Exclusion Criteria:

- Patients who arrive at the ED with a previously performed CXR

- Unstable patients with life-threatening injuries who require ongoing resuscitation
We found this trial at
1
site
1428 Madison Ave
New York, New York 10029
(212) 241-6500
Icahn School of Medicine at Mount Sinai Icahn School of Medicine at Mount Sinai is...
?
mi
from
New York, NY
Click here to add this to my saved trials